SCHEMBL13540686

SCHEMBL13540686

CN(CCO)CC1CCC(CNCc2ccc(-c3ccc(Cl)cc3)o2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.51
HTT P42858 2/20 0.50
USP2 O75604 1/20 0.50
ALDH1A1 P00352 4/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CACNA1G O43497 1/20 0.43
CACNA1B Q00975 1/20 0.43
NPC1 O15118 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SLC2A1 P11166 1/20 0.38
KCNH2 Q12809 2/20 0.38
MCHR1 Q99705 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
GFER P55789 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9906716 0.90 POLB (0.39) POLBHTTUSP2ALDH1A1NPSR1
SCHEMBL13540714 0.81 KMT2A (0.51) NPC1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL9906715 0.72 POLB (0.51) POLBHTTUSP2ALDH1A1NPSR1
Hydrochloric Acid SCHEMBL11635578 0.71 L3MBTL1 (0.69) POLBHTTUSP2ALDH1A1NPSR1
SCHEMBL9906706 0.70 CXCR4 (0.44) NPC1MEN1KMT2ASMN1; SMN2HPGD
SCHEMBL13540772 0.67 ALDH1A1 (0.40) POLBHTTUSP2ALDH1A1NPSR1
SCHEMBL9906689 0.67 MEN1 (0.36) NPC1MEN1KMT2ASLC2A1MAPT
SCHEMBL11663843 0.67 HTT (0.58) POLBHTTUSP2ALDH1A1NPSR1
Hydrochloric Acid SCHEMBL11638310 0.66 HTT (0.57) POLBHTTUSP2ALDH1A1NPSR1
SCHEMBL15706401 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652039-B2 Such as 1-(2-((3-(4-chlorophenoxy)benzyl)amino)-3-phenyl-propyl)piperidin-4-ol for treatment of tuberculosis; solid phase synthesis SEQUELLA, INC. (US) 2010-01-26 US disclosed